Markets:

Overview

News

Currencies

International

Treasuries

Bionano Genomics, Inc. - Common Stock (NQ:BNGO)

1.315 -0.115 (-8.04%)

Delayed Quote Updated: 12:06 PM EDT, Oct 12, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Bionano Genomics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Why BioNano Genomics Traded Higher Today ↗

May 13, 2021

BioNano Genomics Inc (NASDAQ:BNGO) shares traded higher by...

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

May 13, 2021

Gainers Bionano Genomics (NASDAQ:BNGO) st...

Via Benzinga

Is Reddit Favorite BioNano Genomics About To Nosedive? ↗

May 13, 2021

BioNano Genomics (NASDAQ:BNGO) is testing an important sup...

Via Benzinga

The Daily Biotech Pulse: Merck Reports Positive Keytruda Data In Breast Cancer, Curis, Evoke Slump On Earnings, Qiagen's Rapid COVID-19 Antibody Test OK'ed For Emergency Use ↗

May 13, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 12) Alexion Pharmaceuticals, Inc...

Via Benzinga

Is Bionano Genomics a Buy Ahead of Earnings? ↗

May 12, 2021

Don’t mistake Bionano for just any Reddit stock. With its Q1 earnings looming, BNGO stock is attractively priced near its 2021 low.

Via InvestorPlace

Don’t Look Now, but Bionano Genomics May Be a Buy ↗

May 07, 2021

Bionano Genomics lost a lot of supporters in recent months and some never came to the rescue, but a lifeline has been thrown to BNGO stock.

Via InvestorPlace

Don’t Confuse Bionano Genomics As an Investment Right Now ↗

May 03, 2021

The science underlining BNGO stock is incredibly compelling. But that’s not what the market actually cares about right now.

Via InvestorPlace

Bionano Genomics Has Disappointed, but Its NHS Deal May Turn Things Around ↗

April 30, 2021

It's hard to reconcile the sell-off in BNGO stock with Bionano's progress in advancing the Saphyr system - but this presents an opportunity.

Via InvestorPlace

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

April 27, 2021

Gainers Vaxart (NASDAQ:VXRT) shares moved upwards by 53.38% to $9.29 during Tuesday's regular session. Vaxart's stock is trading at a volume of 115.1 million...

Via Benzinga

What's Going On With Bionano Genomics Stock Today? ↗

April 26, 2021

BioNano Genomics Inc (NASDAQ:BNGO) shares are trading higher by 19.5% at $7.36 Mon...

Via Benzinga

The Week Ahead In Biotech (May 9-15): Heron, Apellis FDA Decisions, Presentations and Earnings ↗

May 09, 2021

Biotech stocks came under pressure in the week ended May 7 as traders digested a slew of earnings news flow and a handful of clinical trial readouts. COVID-19 vaccine stocks came...

Via Benzinga

Why Cyclerion, Sol-Gel, Aldeyra, DermTech and Bionano Genomics Are Moving Today ↗

April 27, 2021

Cyclerion Therapeutics, Inc. (NASDAQ: CYCN), Sol-Gel Technologies Ltd. (NASDAQ: SLGL), Aldeyra Therapeutics, Inc. (NASDAQ: ALDX), DermTech, Inc. (NASDAQ: DMTK) and Bionano...

Via Benzinga

58 Biggest Movers From Yesterday ↗

April 27, 2021

Gainers Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) shares jumped 104.2% to close at $8.70 on Monday after the company announced the full details of its Phase 2 trial...

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

April 26, 2021

Gainers Reviva Pharmaceuticals (NASDAQ:RVPH) shares rose 72.91% to $7.47 during Monday's regular session. Reviva Pharmaceuticals's stock is trading at a volume of...

Via Benzinga

Bionano’s UK Deal Is Huge for BNGO Stock ↗

April 23, 2021

Bionano's deal with the UK's National Health Service validates the company's Saphyr system and puts it on the road to becoming a global powerhouse

Via InvestorPlace

Global Market For Sleep Aid Devices Could Reach $112.7 Billion By 2025

April 23, 2021

Via FinancialNewsMedia

Is Bionano Genomics a Buy? ↗

April 23, 2021

Can you count on this company's novel gene diagnostic technology?

Via The Motley Fool

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

April 22, 2021

Gainers Renalytix AI (NASDAQ:RNLX) stock moved upwards by 20.93% to $30.5 during Thursday's pre-market session. The market value of their outstanding shares is at $1.0...

Via Benzinga

Topics Artificial Intelligence

20 Stocks Moving in Thursday's Pre-Market Session ↗

April 22, 2021

Gainers Teradata Corporation (NYSE: TDC) shares rose 29% to $51.45 in pre-market trading after the company raised its Q1 earnings guidance. SeaChange International, Inc. (NYSE:...

Via Benzinga

2 Biopharma Stocks That Look Ready For A Bullish Reversal ↗

April 21, 2021

Ocugen Inc. (NASDAQ: OCGN) and Bionano Inc. (NASDAQ: BNGO) are two biopharma stocks moving higher Wednesday. Ocugen is moving after its partner Bharat Biotech announced...

Via Benzinga

Why Bionano Genomics, Ocugen Are Rallying Today ↗

April 21, 2021

Bionano Genomics, Inc. (NASDAQ: BNGO) and Ocugen, Inc. (NASDAQ: OCGN) were among the early movers among biopharma stocks. Bionano Gains On Adoption of Genomic Mapping System By U....

Via Benzinga

Should You Buy Bionano Genomics in April? ↗

April 18, 2021

This stock market mover's growth story is just beginning.

Via The Motley Fool

Why Bionano Genomics Stock Is Tumbling Today ↗

April 16, 2021

No news; just run-of-the-mill volatility.

Via The Motley Fool

Bionano Genomics Stock Is Too Wild for Its Own Good ↗

April 09, 2021

BNGO stock has seen too much action without fundamental justification. It makes a better speculative bet than an investment.

Via InvestorPlace

Bionano Genomics Stock Has Huge Potential, But It’s Very Risky ↗

April 09, 2021

BNGO stock is a play on a potentially disruptive technology. But investors can't forget that most potentially disruptive technologies fail.

Via InvestorPlace

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.